Cargando…

Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain

BACKGROUND: Sporadic late-onset Alzheimer's disease (AD) appears to evolve from an interplay between genetic and environmental factors. One environmental factor that continues to be of great interest is that of Chlamydia pneumoniae infection and its association with late-onset disease. Detectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammond, Christine J, Hallock, Loretta R, Howanski, Raymond J, Appelt, Denah M, Little, C Scott, Balin, Brian J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949767/
https://www.ncbi.nlm.nih.gov/pubmed/20863379
http://dx.doi.org/10.1186/1471-2202-11-121
_version_ 1782187574571302912
author Hammond, Christine J
Hallock, Loretta R
Howanski, Raymond J
Appelt, Denah M
Little, C Scott
Balin, Brian J
author_facet Hammond, Christine J
Hallock, Loretta R
Howanski, Raymond J
Appelt, Denah M
Little, C Scott
Balin, Brian J
author_sort Hammond, Christine J
collection PubMed
description BACKGROUND: Sporadic late-onset Alzheimer's disease (AD) appears to evolve from an interplay between genetic and environmental factors. One environmental factor that continues to be of great interest is that of Chlamydia pneumoniae infection and its association with late-onset disease. Detection of this organism in clinical and autopsy samples has proved challenging using a variety of molecular and histological techniques. Our current investigation utilized immunohistochemistry with a battery of commercially available anti-C. pneumoniae antibodies to determine whether C. pneumoniae was present in areas typically associated with AD neuropathology from 5 AD and 5 non-AD control brains. RESULTS: Immunoreactivity for C. pneumoniae antigens was observed both intracellularly in neurons, neuroglia, endothelial cells, and peri-endothelial cells, and extracellularly in the frontal and temporal cortices of the AD brain with multiple C. pneumoniae-specific antibodies. This immunoreactivity was seen in regions of amyloid deposition as revealed by immunolabeling with two different anti-beta amyloid antibodies. Thioflavin S staining, overlaid with C. pneumoniae immunolabeling, demonstrated no direct co-localization of the organism and amyloid plaques. Further, the specificity of C. pneumoniae labeling of AD brain sections was demonstrated using C. pneumoniae antibodies pre-absorbed against amyloid β 1-40 and 1-42 peptides. CONCLUSIONS: Anti-C. pneumoniae antibodies, obtained commercially, identified both typical intracellular and atypical extracellular C. pneumoniae antigens in frontal and temporal cortices of the AD brain. C. pneumoniae, amyloid deposits, and neurofibrillary tangles were present in the same regions of the brain in apposition to one another. Although additional studies are required to conclusively characterize the nature of Chlamydial immunoreactivity in the AD brain, these results further implicate C. pneumoniae infection with the pathogenesis of Alzheimer's disease.
format Text
id pubmed-2949767
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29497672010-10-06 Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain Hammond, Christine J Hallock, Loretta R Howanski, Raymond J Appelt, Denah M Little, C Scott Balin, Brian J BMC Neurosci Methodology Article BACKGROUND: Sporadic late-onset Alzheimer's disease (AD) appears to evolve from an interplay between genetic and environmental factors. One environmental factor that continues to be of great interest is that of Chlamydia pneumoniae infection and its association with late-onset disease. Detection of this organism in clinical and autopsy samples has proved challenging using a variety of molecular and histological techniques. Our current investigation utilized immunohistochemistry with a battery of commercially available anti-C. pneumoniae antibodies to determine whether C. pneumoniae was present in areas typically associated with AD neuropathology from 5 AD and 5 non-AD control brains. RESULTS: Immunoreactivity for C. pneumoniae antigens was observed both intracellularly in neurons, neuroglia, endothelial cells, and peri-endothelial cells, and extracellularly in the frontal and temporal cortices of the AD brain with multiple C. pneumoniae-specific antibodies. This immunoreactivity was seen in regions of amyloid deposition as revealed by immunolabeling with two different anti-beta amyloid antibodies. Thioflavin S staining, overlaid with C. pneumoniae immunolabeling, demonstrated no direct co-localization of the organism and amyloid plaques. Further, the specificity of C. pneumoniae labeling of AD brain sections was demonstrated using C. pneumoniae antibodies pre-absorbed against amyloid β 1-40 and 1-42 peptides. CONCLUSIONS: Anti-C. pneumoniae antibodies, obtained commercially, identified both typical intracellular and atypical extracellular C. pneumoniae antigens in frontal and temporal cortices of the AD brain. C. pneumoniae, amyloid deposits, and neurofibrillary tangles were present in the same regions of the brain in apposition to one another. Although additional studies are required to conclusively characterize the nature of Chlamydial immunoreactivity in the AD brain, these results further implicate C. pneumoniae infection with the pathogenesis of Alzheimer's disease. BioMed Central 2010-09-23 /pmc/articles/PMC2949767/ /pubmed/20863379 http://dx.doi.org/10.1186/1471-2202-11-121 Text en Copyright ©2010 Hammond et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology Article
Hammond, Christine J
Hallock, Loretta R
Howanski, Raymond J
Appelt, Denah M
Little, C Scott
Balin, Brian J
Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain
title Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain
title_full Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain
title_fullStr Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain
title_full_unstemmed Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain
title_short Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain
title_sort immunohistological detection of chlamydia pneumoniae in the alzheimer's disease brain
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949767/
https://www.ncbi.nlm.nih.gov/pubmed/20863379
http://dx.doi.org/10.1186/1471-2202-11-121
work_keys_str_mv AT hammondchristinej immunohistologicaldetectionofchlamydiapneumoniaeinthealzheimersdiseasebrain
AT hallocklorettar immunohistologicaldetectionofchlamydiapneumoniaeinthealzheimersdiseasebrain
AT howanskiraymondj immunohistologicaldetectionofchlamydiapneumoniaeinthealzheimersdiseasebrain
AT appeltdenahm immunohistologicaldetectionofchlamydiapneumoniaeinthealzheimersdiseasebrain
AT littlecscott immunohistologicaldetectionofchlamydiapneumoniaeinthealzheimersdiseasebrain
AT balinbrianj immunohistologicaldetectionofchlamydiapneumoniaeinthealzheimersdiseasebrain